Global Health Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27
- July 1, 2026
- Posted by: Lakshit Sharma
- Category: News
Global Health (Medanta) Rs 1,332.60 (5 Oct 2026 close). 52-week range Rs 956 to Rs 1,544. Q1 FY27 revenue up 26.5%. ARPOB Rs 70,244.
Quick Answer
The Global Health share price target for 2026 is Rs 1,254 to Rs 1,452, which is between 6 percent below and 9 percent above the last close of Rs 1,332.60, with bull and bear cases of Rs 1,760 to Rs 1,920 and Rs 832 to Rs 936. Global Health, which runs Medanta hospitals, reported Q1 FY27 revenue up 26.5 percent to Rs 1,304 crore and EBITDA up 23.5 percent to Rs 315 crore, with ARPOB up 5.5 percent to Rs 70,244, while profit of Rs 157.25 crore was flat on a one-time gain a year earlier. The Noida hospital’s EBITDA loss narrowed to Rs 4.9 crore from Rs 23.6 crore, the company plans to add about 3,350 beds over five years, and the stock fell about 9 percent in the week of 28 September to Rs 1,332.60. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario.
The Global Health share price target for 2026 is Rs 1,254 to Rs 1,452 in the Univest base case, with the stock at Rs 1,332.60 at the 5 October 2026 close. That is 13.7 percent below its 52-week high of Rs 1,544.00 and 39.4 percent above its 52-week low of Rs 956.00, and the stock moved down 1.2 percent over the past year. Global Health runs the Medanta chain of super-specialty hospitals with 3,737 operational beds and a Rs 4,850 crore plan to add about 3,350 beds in Varanasi, Guwahati, Mumbai and South Delhi. Debt to equity is 0.30.
Three things changed since the last update: Q1 FY27 results on 31 July showed the Noida hospital’s loss narrowing, the stock hit a high of Rs 1,544 in August, and it fell 9 percent in the week of 28 September. This Global Health stock analysis covers the Global Health share price today, the Global Health share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Global Health buy or sell view.
Click Here – Get Free Investment Predictions
What Is the Global Health Share Price Target for 2026?
The 2026 target for Global Health shares is Rs 1,254 to Rs 1,452 in the Univest base case, which is -5.9% to +9.0% against the last close. The bull case is Rs 1,760 to Rs 1,920 and the bear case is Rs 832 to Rs 936. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.
Global Health Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS | Target Multiple | Price Target (Rs) | Move vs Rs 1,332.60 |
|---|---|---|---|---|
| Bull Case | Rs 40 | 44x to 48x | 1,760 to 1,920 | +32.1% to +44.1% |
| Base Case | Rs 33 | 38x to 44x | 1,254 to 1,452 | -5.9% to +9.0% |
| Bear Case | Rs 26 | 32x to 36x | 832 to 936 | -37.6% to -29.8% |
FY28 EPS of Rs 33 in the base case is above trailing EPS of Rs 20.54 and assumes Noida reaches breakeven and occupancy near 66 percent. The multiples sit near the industry average of 64 times at the low end, and the bear case assumes expansion costs and weak occupancy hold earnings down. The PE multiple used for each case is shown in the table, and the EPS estimate is a Univest assumption, not company guidance. Those assumptions set the Global Health share price target range around the current price.
Global Health Company Overview and Share Price Today as of 5 October 2026
Global Health share price today is Rs 1,332.60 on the NSE at the 5 October 2026 close, before the market opened on 6 October. The market capitalisation is Rs 35,806 crore, and the stock trades at 64.8 times earnings, in line with the industry average of 64.1 times. The Univest base case Global Health share price target of Rs 1,254 to Rs 1,452 is -5.9% to +9.0% from here. The table below sets out the key numbers behind the Global Health share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | MEDANTA | BSE code 543654 |
| Sector | Hospitals | Per Univest sector classification |
| Last Close (NSE) | Rs 1,332.60 | 5 Oct 2026 close |
| 52-Week High | Rs 1,544.00 | CMP is 13.7% below |
| 52-Week Low | Rs 956.00 | CMP is 39.4% above |
| 1-Year Return | About -1% | Weekly close Rs 1,349.40 on 3 Oct 2025 to Rs 1,332.60 |
| Market Capitalisation | Rs 35,806 crore | Mid cap hospital chain |
| Trailing P/E | About 64.8x | Industry P/E about 64.1x |
| P/B Ratio | About 9.04x | Book value Rs 147.34 per share |
| EPS (TTM) | Rs 20.54 | Trailing twelve months |
| Return on Equity | About 14.1% | Debt to equity 0.30 |
| Dividend Yield | About 0.04% | Small dividend |
| 12-Month Target (Base Case) | Rs 1,254 to Rs 1,452 | Univest base case |
| Bull Case | Rs 1,760 to Rs 1,920 | +32.1% to +44.1% |
| Bear Case | Rs 832 to Rs 936 | -37.6% to -29.8% |
Track live price, fundamentals and results for Global Health on the Univest Screener.
How Did Global Health Perform in Q1 FY27?
Global Health reported Q1 FY27 consolidated revenue from operations of Rs 1,304.05 crore, up 26.5 percent, EBITDA of Rs 315.3 crore, up 23.5 percent, and net profit of Rs 157.25 crore against Rs 158.98 crore. Last year included a one-time gain of Rs 19.6 crore. Together these Q1 FY27 numbers anchor the Global Health share price target.
| Metric | Q1 FY27 | Context |
|---|---|---|
| Revenue from Operations | Rs 1,304.05 crore | Up 26.5% year on year |
| EBITDA | Rs 315.3 crore | Up 23.5%; margin 23.8% |
| Net Profit | Rs 157.25 crore | Flat; prior year had a Rs 19.6 crore gain |
| ARPOB | Rs 70,244 | Up 5.5% |
| Occupancy | About 63% | 66% excluding Noida |
| Noida Hospital EBITDA | Loss of Rs 4.9 crore | Against Rs 23.6 crore loss in Q4 FY26 |
International patient revenue grew 23 percent to Rs 78.2 crore and the OPD pharmacy grew 50.9 percent to Rs 60.9 crore, and 72 beds were added in the quarter. Noida opened in November 2025 and its income rose to Rs 85.5 crore. The FY27 outlook from management is the main input for these estimates. These numbers sit behind every range in the scenario table above, so they anchor the Global Health share price target.
Why Did Global Health Share Price Fall 9 Percent in One Week?
Global Health shares fell 9.2 percent in the week of 28 September 2026 from Rs 1,495 to Rs 1,357, on volume of 11.4 lakh shares, and the sources we checked do not confirm a single cause. The stock had hit a 52-week high of Rs 1,544 in the week of 24 August.
The stock is flat in a year at Rs 1,332.60 after a rise of 61 percent from the Rs 956 low of March 2026. Flat profit growth against a 65 times multiple leaves it sensitive to profit-taking. The Global Health share price target scenarios below account for that move.
Key Catalysts for the Global Health Share Price Target in 2026
4 catalysts matter most for the Global Health share price target, and sector tailwinds in Hospitals are part of the case. Together they decide whether the base case is reached.
1. Noida Ramp-Up
Noida’s EBITDA loss fell from Rs 23.6 crore to Rs 4.9 crore as income rose to Rs 85.5 crore. Breakeven would lift group profit. If it plays out, the Global Health share price target moves toward the top of the base range.
2. Bed Expansion
A Rs 4,850 crore plan adds about 3,350 beds in Varanasi, Guwahati, Mumbai and South Delhi. New beds drive growth beyond FY28. Strength here would support the upper end of the Global Health share price target.
3. Higher ARPOB
ARPOB rose 5.5 percent on a richer case mix and shorter stays. Cardiac, neuro and oncology care keep it rising. Delivery on this point keeps the Global Health share price target on track.
4. International and Pharmacy
International patient revenue grew 23 percent and the OPD pharmacy 50.9 percent. Both add income per patient. Better news here would lift the Global Health share price target toward the bull case.
What Are the Key Risks to the Global Health Share Price Target?
The main risks are expansion costs, occupancy, a premium valuation and slow Noida ramp-up. Each can pull the Global Health share price target lower.
Expansion Costs
The Rs 4,850 crore plan raises depreciation and interest before new beds fill. Heavy spending would hold profit down. If it materialises, the Global Health share price target would slip toward the bear case.
Occupancy
Occupancy was 63 percent on a larger bed base. A fall would cut margin. This is the main downside risk to the Global Health share price target.
Premium Valuation
The stock trades at 64.8 times earnings and 9.0 times book. A de-rating toward 32 times FY28 EPS of Rs 26 would put the price near Rs 830. A worsening here would cut the Global Health share price target toward the low end of the range.
Slow Noida Ramp-Up
Noida is still loss-making at EBITDA level. A slower ramp-up would delay group margin gains. Watch it closely, because it can pull the Global Health share price target lower quickly.
Global Health Stock Analysis: Support and Resistance Levels for the Share Price Target
Global Health stock analysis on weekly charts shows a range of Rs 1,321 to Rs 1,527 since mid-September, with the stock near the lower end.
The first support level is Rs 1,321 to Rs 1,336, the lows of the weeks of 5 and 28 September. Below that, Rs 1,295 to Rs 1,312 marks the June and July lows, and a weekly close under Rs 1,321 would weaken the base.
The first resistance level is Rs 1,369, the high of the week of 5 October. Above that, Rs 1,403 to Rs 1,447 marks the early-September range, and Rs 1,495 to Rs 1,544 the late-August and mid-September highs. These levels come from weekly price action, are not trade recommendations, and frame the near-term Global Health share price target.
Global Health Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term Global Health Share Price Target (3 to 6 Months)
In the near term the stock is likely to trade between Rs 1,321 and Rs 1,403, from the late-September low to the early-September low. A close above Rs 1,403 would put Rs 1,447 in play, while a weekly close under Rs 1,321 would put Rs 1,295 in play. The Q2 FY27 results are the main trigger. This range anchors the near-term Global Health share price target.
12-Month and 2027 Global Health Share Price Target
The 12-month target price is Rs 1,254 to Rs 1,452, valued on 38 to 44 times FY28 EPS of Rs 33. The range across scenarios runs from Rs 832 in the bear case to Rs 1,920 in the bull case.
Long-Term Global Health Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 1,680 to Rs 2,320. This assumes EPS of Rs 48 in FY29 and Rs 58 in FY30 and a multiple of 35 to 40 times. It needs new beds to fill and Noida to reach scale. This is the long-term Global Health share price target in the Univest scenarios.
Bull Case and Bear Case for Global Health Share Price Target
Bull Case Rs 1,760 to Rs 1,920
The bull case of Rs 1,760 to Rs 1,920 for the Global Health share price target needs EPS of Rs 40 and the market to pay 44 to 48 times for it. It is +32.1% to +44.1% from the last close.
Bear Case Rs 832 to Rs 936
The bear case of Rs 832 to Rs 936 for the Global Health share price target equals 32 to 36 times FY28 EPS of Rs 26 and sits below the Rs 956 low. It is -37.6% to -29.8% from the last close.
Is Global Health a Good Buy at Rs 1,333? Global Health Buy or Sell View
Whether Global Health is a buy at Rs 1,332.60 depends on horizon and risk appetite. The base case implies -6 to 9 percent from here, the stock is 14 percent below its high, and the open question is Noida. The Global Health share price target range is the starting point for that decision.
Long-term holders may focus on bed expansion, ARPOB and Noida, and treat Rs 1,321 as the level to watch. Short-term traders may prefer to wait for a close above Rs 1,403. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Global Health buy or sell view is educational.
How to Invest in Global Health Shares
Step 1: Check the live price, valuation and the latest Global Health share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Global Health share price target.
Step 3: Search for MEDANTA on the NSE or 543654 on the BSE in your trading app.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 832 is bearable.
Step 5: Track Noida, occupancy and Q2 FY27 results and set price alerts on the Univest App to follow any change in the Global Health share price target.
Conclusion
Global Health closed at Rs 1,332.60 against a Univest base case share price target of Rs 1,254 to Rs 1,452, a bull case of Rs 1,760 to Rs 1,920 and a bear case of Rs 832 to Rs 936. Q1 FY27 delivered a 26.5 percent revenue rise to Rs 1,304.05 crore with flat profit of Rs 157.25 crore, and the Noida loss narrowed. The main risks are expansion costs, occupancy and valuation.
The stock is 13.7 percent below its 52-week high, so the base case implies roughly -6 to 9 percent from here. The triggers to watch are Noida, the Q2 FY27 results and the Rs 1,321 and Rs 1,403 levels. Re-check the Global Health share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track Global Health live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Global Health Share Price Target 2026
What is the Global Health share price target for 2026?
Ans. The Global Health share price target for 2026 is Rs 1,254 to Rs 1,452 in the Univest base case, with a bull case of Rs 1,760 to Rs 1,920 and a bear case of Rs 832 to Rs 936. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario. These are estimates and can change after the Q2 FY27 results.
What is the Global Health share price target for 2027?
Ans. The Global Health share price target for 2027 is Rs 1,254 to Rs 1,452 in the base case, valued on 38 to 44 times FY28 EPS of Rs 33. The scenario range runs from Rs 832 to Rs 1,920.
Is Global Health a good buy at Rs 1,332.60?
Ans. Whether Global Health is a good buy at Rs 1,332.60 depends on your horizon, risk appetite and how you read the Global Health share price target. Revenue is growing 26 percent and Noida’s loss is narrowing, but profit was flat and the stock trades at about 65 times earnings. Consult a SEBI-registered advisor before investing.
What are the key risks to the Global Health share price target?
Ans. The key risks to the Global Health share price target are expansion costs, occupancy, premium valuation and slow noida ramp-up. The Rs 4,850 crore plan raises depreciation and interest before new beds fill. Heavy spending would hold profit down.
What are the key catalysts for the Global Health share price target?
Ans. The key catalysts for the Global Health share price target are noida ramp-up, bed expansion, higher arpob and international and pharmacy. Noida’s EBITDA loss fell from Rs 23.6 crore to Rs 4.9 crore as income rose to Rs 85.5 crore. Breakeven would lift group profit.
Where can I track Global Health share price today and Global Health share price target updates?
Ans. You can track the live Global Health share price, results and any change to the Global Health share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are Global Health’s 52-week high and low?
Ans. Global Health’s 52-week high is Rs 1,544.00 and its 52-week low is Rs 956.00, based on weekly NSE data. At Rs 1,332.60 the stock is 13.7 percent below the high and 39.4 percent above the low. Both levels frame the Global Health share price target.
How to buy Global Health shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for MEDANTA on the NSE or 543654 on the BSE, and place a limit order near your entry price, using the Global Health share price target range as a guide. Size the position so a fall to Rs 832 is bearable, and check the live price on the Univest Screener first.